Literature DB >> 8943983

Angiotensin-converting enzyme activity in stools of healthy subjects and patients with celiac disease.

C Letizia1, A Picarelli, A De Ciocchis, F Di Giovambattista, M Greco, S Cerci, A Torsoli, D Scavo.   

Abstract

Angiotensin-converting enzyme (ACE) is a dipeptidylcarboxypeptidase that occurs in three types of cells: endothelial, epithelial, and neuroepithelial. ACE activity is present in plasma, urine, and vascular endothelium. High levels of ACE are found in the brush border of human small bowel. The aim of this study was to evaluate ACE activity in human stools and to find a correlation with the intestinal loss of epithelial cells. Fifteen healthy subjects (HS) (8 males, 7 females; age range 6-56 years), 20 patients with celiac disease (CD) (11 males, 9 females; age range 15-53 years), and 18 patients with CD in remission after a gluten-free diet (CD-GFD) (8 males, 10 females; age range 14-54 years) were enrolled in the study. The fecal ACE activity was measured in all groups. Fecal samples were kept at -20 degrees C for a subsequent test. In HS, fecal ACE activity was 21.03 +/- 16.17 nmol/min/100 g (mean +/- SD). In patients with CD with subtotal mucosa atrophy, ACE activity was significantly higher (113 +/- 88.94) than in HS and CD on GFD (36.65 +/- 23.9). We have demonstrated ACE activity in human stools. ACE activity in stools seems to derive from the microvilli of the intestinal mucosa, thus suggesting the potential usefulness of ACE determination as an index of enterocyte damage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943983     DOI: 10.1007/bf02071411

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  13 in total

Review 1.  Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue').

Authors:  M N Marsh
Journal:  Gastroenterology       Date:  1992-01       Impact factor: 22.682

2.  Subcellular localization of pulmonary antiotensin-converting enzyme (kininase II).

Authors:  J W Ryan; U S Ryan; D R Schultz; C Whitaker; A Chung
Journal:  Biochem J       Date:  1975-02       Impact factor: 3.857

3.  The angiotensin I-converting enzyme.

Authors:  E G Erdös; R A Skidgel
Journal:  Lab Invest       Date:  1987-04       Impact factor: 5.662

Review 4.  The site of angiotensin production.

Authors:  D J Campbell
Journal:  J Hypertens       Date:  1985-06       Impact factor: 4.844

5.  Converting-enzyme in the choroid plexus, brain, and kidney: immunocytochemical and biochemical studies in rats.

Authors:  E Rix; D Ganten; B Schüll; T Unger; R Taugner
Journal:  Neurosci Lett       Date:  1981-03-10       Impact factor: 3.046

6.  Angiotensin I converting enzyme (kininase II) of the brush border of human and swine intestine.

Authors:  P E Ward; M A Sheridan; K J Hammon; E G Erdös
Journal:  Biochem Pharmacol       Date:  1980-06-01       Impact factor: 5.858

7.  Serum angiotensin converting enzyme in diabetic retinopathy.

Authors:  C Letizia; P Repossi; M Sellini; S Cerci; G Santi; A M De Negri; M Pannarale; D Scavo
Journal:  Int J Tissue React       Date:  1992

8.  Isolation and characterization of angiotensin converting enzyme from human kidney.

Authors:  Y Takada; K Hiwada; T Kokubu
Journal:  J Biochem       Date:  1981-11       Impact factor: 3.387

9.  Purification and characterization of human converting enzyme (kininase II).

Authors:  T A Stewart; J A Weare; E G Erdös
Journal:  Peptides       Date:  1981       Impact factor: 3.750

10.  Angiotensin-converting enzyme in epithelial and neuroepithelial cells.

Authors:  R Defendini; E A Zimmerman; J A Weare; F Alhenc-Gelas; E G Erdös
Journal:  Neuroendocrinology       Date:  1983-07       Impact factor: 4.914

View more
  2 in total

1.  Local corticosterone production and angiotensin-I converting enzyme shedding in a mouse model of intestinal inflammation.

Authors:  Hanne Salmenkari; Tomi Issakainen; Heikki Vapaatalo; Riitta Korpela
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

2.  Reduced severity of a mouse colitis model with angiotensin converting enzyme inhibition.

Authors:  Ariel U Spencer; Hua Yang; Emir Q Haxhija; Barbara E Wildhaber; Joel K Greenson; Daniel H Teitelbaum
Journal:  Dig Dis Sci       Date:  2007-03-07       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.